510(k) device
Catalyze
BioTissue Holdings, Inc. · Wound Dressing With Animal-Derived Material(S) (KGN, Unclassified) · First FDA decision Jun 5, 2026, newest Jun 5, 2026BurnsChronic wounds and ulcers
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
3
Naming "Catalyze"
MAUDE reports
0
Brand "Catalyze", since 2015
PubMed studies
42,127
Mentioning "Catalyze"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Catalyze
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Catalyze510(k)
K253204 · Decided Jun 5, 2026 · 252 days after receipt
Device type: Wound Dressing With Animal-Derived Material(S) (KGN) · General & Plastic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Catalyze", any status and sponsor, newest update first.
- Acute Recording of Stereotyped High-Frequency OscillationsActive, not recruiting
Mayo ClinicAcademic, hospital or other
NCT05439655 · 17 participants · Start Sep 1, 2021 · Primary completion Aug 11, 2025
Device: Brain Interchange System · For: Epilepsy
Sites: Rochester, Minnesota; Houston, Texas
Mayo ClinicAcademic, hospital or other
NCT06898138 · 8 participants (planned) · Start Nov 1, 2026 · Primary completion Feb 15, 2029
Device: Brain Interchange System · For: Epilepsy
Sites: Rochester, Minnesota; Houston, Texas
University of California, San FranciscoAcademic, hospital or other
NCT02477774 · 55 participants · Start Jul 2016 · Primary completion Dec 2020
Device: ARISTA · For: Seroma
Sites: San Francisco, California
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Catalyze", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code KGN
154 reports: 32 malfunction, 117 injury, 1 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Catalyze"[tiab]. The summary above synthesizes these.
- 2-Oxoglutarate-Dependent Oxygenases.
Islam MS, Leissing TM, Chowdhury R, et al. · Annu Rev Biochem · 2018Research Support, Non-U.S. Gov't, Review
- Class I histone deacetylases catalyze lysine lactylation.
Gonzatti MB, Hintzen JCJ, Sharma I, et al. · J Biol Chem · 2025Research Support, N.I.H., Extramural
- Flavoenzymes.
Joosten V, van Berkel WJ · Curr Opin Chem Biol · 2007Research Support, Non-U.S. Gov't, Review
- Flavin-dependent halogenases catalyze enantioselective olefin halocyclization.
Mondal D, Fisher BF, Jiang Y, et al. · Nat Commun · 2021Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- Is Drp1 sufficient to catalyze membrane fission?
Roy K, Pucadyil TJ · Proc Natl Acad Sci U S A · 2022Letter, Research Support, Non-U.S. Gov't
- Nickel-based Enzyme Systems.
Ragsdale SW · J Biol Chem · 2009Review
- Taxol biosynthetic genes.
Walker K, Croteau R · Phytochemistry · 2001Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- The galactosyltransferase family.
Hennet T · Cell Mol Life Sci · 2002Research Support, Non-U.S. Gov't, Review
- Biosynthesis of cytokinins.
Kakimoto T · J Plant Res · 2003Review
- ChemOS: Orchestrating autonomous experimentation.
Roch LM, Häse F, Kreisbeck C, et al. · Sci Robot · 2018Review, Research Support, Non-U.S. Gov't
- Amyloid Fibers of α-Synuclein Catalyze Chemical Reactions.
Horvath I, Wittung-Stafshede P · ACS Chem Neurosci · 2023Research Support, Non-U.S. Gov't
- Staphylococcus aureus functional amyloids catalyze degradation of β-lactam antibiotics.
Arad E, Pedersen KB, Malka O, et al. · Nat Commun · 2023Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code KGN.
- Cytal® Wound MatrixAcell, Inc. · 510(k) 2024
- PriMatrix Dermal Repair ScaffoldTei Biosciences, Inc. · 510(k) 2016
- Marigen Wound ExtraKerecis Limited · 510(k) 2025
- MatriDermMedskin Solutions Dr. Suwelack AG · 510(k) 2026
- CollOvine Wound PowderOvigenex, LLC · 510(k) 2026
- SurgiAid Collagen Wound Dressing (HA)Maxigen Biotech, Inc. · 510(k) 2025
- Collagen Wound DressingWinner Medical Co., Ltd. · 510(k) 2025
- Corplex P/ Theracor P/ Allacor PStimlabs, LLC · 510(k) 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.